by cristiano | Oct 17, 2018
The recent development of bioresorbable coronary stents (Bioresorbable Vascular Scaffolds, BVS) represent a promising therapeutic option as compared with traditional drug-eluting stents (DES). However, based on the most recent evidence currently available, BVS (the...
by cristiano | Oct 17, 2018
The population at increased risk for developing influenza is represented by subjects aged ≥65 years or suffering from co-morbidities. However, defining the “place in therapy” of the different types of influenza vaccine is difficult because comparative studies based on...
by cristiano | Oct 17, 2018
The results of numerous prospective clinical studies indicate that chemotherapy administered to patients with metastatic cancer in their last 30 days of life is ineffective and leads, particularly in the last week of life, to an increased utilization of intensive care...
by cristiano | Oct 17, 2018
Generic drugs have the same composition as branded drugs and possess similar effectiveness, but their cost is 30 to 70% lower. In Italy, the increased use of generics from 2010 al 2014 (+55% as DDD/1000 inhabitants/day) has determined a saving in the pharmaceutical...
by cristiano | Oct 17, 2018
Shared planning of care is provided for by Law 219/2017 “Rules on Informed Consent and Advance Treatment Provisions”. It allows the sick person, if desired, and the treating physician to align themselves on the goals of care, on futile or disproportionate...
Recent Comments